Profil
Claudia D'Augusta is currently the Chief Financial Officer at VectivBio Holding AG since 2019.
She previously worked as an Independent Non-Executive Director at ReNeuron Group Plc from 2017 to 2020, and as a Non-Executive Director at Bone Therapeutics SA in 2018.
Claudia also held various finance and directorial positions at Aquanima Management Consulting, Sensia SL, TiGenix NV, Deloitte & Touche LLP, and Cellerix SA. She was an Operational Partner at Ysios Capital Partners SGEIC SA from 2018 to 2021 and briefly served as the Chief Financial Officer at Therachon Holding GmbH in 2019.
Dr. D'Augusta received her undergraduate and doctorate degrees from the University of Bocconi in 1994 and 1998, respectively.
Anciens postes connus de Claudia D'Augusta
| Sociétés | Poste | Fin |
|---|---|---|
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements. | Private Equity Investor | 30/09/2021 |
| RENEURON GROUP PLC | Directeur/Membre du Conseil | 10/09/2020 |
Therachon Holding GmbH
Therachon Holding GmbH BiotechnologyHealth Technology Develops medical treatments for rare conditions | Directeur Financier/CFO | 01/06/2019 |
| TIGENIX NV | Directeur Financier/CFO | 01/06/2018 |
Cellerix SA
Cellerix SA Pharmaceuticals: GenericHealth Technology Develops and manufactures pharmaceutical products | Directeur Financier/CFO | 01/02/2011 |
Formation de Claudia D'Augusta
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
ReNeuron Group Plc
ReNeuron Group Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and manufactures cell-based therapy products | Health Technology |
TiGenix NV
TiGenix NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapeutic | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
University of Bocconi
University of Bocconi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Banco Santander SA
Banco Santander SA Major BanksFinance Provides banking services for individuals, companies and institutions | Finance |
Cellerix SA
Cellerix SA Pharmaceuticals: GenericHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements. | Finance |
Bone Therapeutics SA
Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops regenerative therapy products for addressing unmet medical needs in the field of bone diseases and orthopedics | Health Technology |
Sensia SL | |
Aquanima Management Consulting
Aquanima Management Consulting Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Therachon Holding GmbH
Therachon Holding GmbH BiotechnologyHealth Technology Develops medical treatments for rare conditions | Health Technology |
VectivBio Holding AG
VectivBio Holding AG Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for rare diseases | Health Technology |
















